S'abonner

Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students - 16/05/19

Doi : 10.1016/j.jaad.2018.08.014 
Rebecca L. Pearl, PhD a, b, , Marilyn T. Wan, MBChB, MPH c, Junko Takeshita, MD, PhD, MSCE c, d, Joel M. Gelfand, MD, MSCE c, d
a Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 
b Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 
c Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 
d Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 

Correspondence to: Rebecca L. Pearl, 3535 Market St, Suite 3026, Philadelphia, PA 19104.3535 Market St, Suite 3026PhiladelphiaPA19104

Abstract

Background

Perceived stigma among patients with psoriasis contributes to poor quality of life.

Objective

To determine the prevalence and predictors of stigmatizing attitudes toward persons with psoriasis among laypersons and medical trainees.

Methods

Laypersons were recruited from Amazon.com's Mechanical Turk (MTurk) (n = 198). Additionally, 187 medical students were recruited via e-mail. Participants completed an online survey in which they viewed images of persons with visible psoriasis. Participants reported their desire to socially avoid the persons in the images, their emotional responses to the persons in the images, and their endorsement of psoriasis-related stereotypes and myths.

Results

MTurk participants endorsed social avoidance items such as not wanting to shake hands with (39.4%) or have the persons in the images in their home (32.3%). Participants stereotyped persons with psoriasis as contagious (27.3%) and endorsed the myth that psoriasis is not a serious disease (26.8%). Linear regression analyses showed that having heard of or knowing someone with psoriasis predicted fewer stigmatizing attitudes (P < .05). The medical students reported less stigmatizing attitudes than the MTurk participants (P < .01).

Limitations

Self-report, single-institution study.

Conclusion

Stigmatizing views of persons with psoriasis are prevalent among people in the United States. Educational campaigns for the public and medical trainees may reduce stigma toward persons with psoriasis.

Le texte complet de cet article est disponible en PDF.

Key words : attitudes, laypersons, medical education, psoriasis, stigma

Abbreviations used : ANCOVA, CI, MTurk, OR, QOL


Plan


 Funding sources: Supported by a grant from the Edwin and Fannie Gray Hall Center for Human Appearance at the Perelman School of Medicine at the University of Pennsylvania. Dr Pearl is supported in part by a mentored patient-oriented research career development award from the National Heart, Lung and Blood Institute/National Institutes of Health (grant K23HL140176). Dr Takeshita is supported in part by a mentored patient-oriented research career development award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (grant 5K23AR068433).
 Disclosure: Dr Gelfand served as a consultant for Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Janssen Biologics, Novartis Corp, Regeneron, UCB (Data Safety and Monitoring Board), and Sanofi and Pfizer Inc, receiving honoraria; in addition, he receives research grants (to the Trustees of the University of Pennsylvania) from Abbvie, Janssen, Novartis Corp, Sanofi, Celgene, Ortho Dermatologics, and Pfizer Inc, and he has received payment for CME work related to psoriasis that was supported indirectly by Eli Lilly and Company and Ortho Dermatologics. In addition, Dr Gelfand is a copatent holder of resiquimod for treatment of cutaneous T-cell lymphoma, and he is a deputy editor for the Journal of Investigative Dermatology, receiving honoraria from the Society for Investigative Dermatology. Dr Takeshita receives a research grant from Pfizer Inc (to the Trustees of the University of Pennsylvania) and has received payment for CME work related to psoriasis that was supported indirectly by Eli Lilly and Company and Novartis. Dr Pearl and Dr Wan have no conflicts of interest to disclose.
 A preliminary analysis of the current data was presented at the 2018 Meeting International Investigative Dermatology, Orlando, FL, May 16-19, 2018.


© 2018  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 80 - N° 6

P. 1556-1563 - juin 2019 Retour au numéro
Article précédent Article précédent
  • Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides
  • Felix Pavlotsky, Marwan Dawood, Aviv Barzilai
| Article suivant Article suivant
  • Developing an international standard for the classification of surface anatomic location for use in clinical practice and epidemiologic research
  • Katherine A. Kenneweg, Allan C. Halpern, Robert J.G. Chalmers, H. Peter Soyer, Michael Weichenthal, Matthew A. Molenda

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.